U01CA233100
Cooperative Agreement
Overview
Grant Description
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Boston,
Massachusetts
02215
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 401% from $841,459 to $4,219,302.
Dana-Farber Cancer Institute was awarded
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
Cooperative Agreement U01CA233100
worth $4,219,302
from National Cancer Institute in September 2018 with work to be completed primarily in Boston Massachusetts United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot.
The Cooperative Agreement was awarded through grant opportunity Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01).
Status
(Complete)
Last Modified 2/20/24
Period of Performance
9/19/18
Start Date
8/31/23
End Date
Funding Split
$4.2M
Federal Obligation
$0.0
Non-Federal Obligation
$4.2M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA233100
Transaction History
Modifications to U01CA233100
Additional Detail
Award ID FAIN
U01CA233100
SAI Number
U01CA233100-2255218676
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
DPMGH9MG1X67
Awardee CAGE
5E915
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $5,058,748 | 100% |
Modified: 2/20/24